Behshad Sheldon is an experienced pharmaceutical executive currently serving as President of Camurus Inc. since May 2018 and as a Board Director for Camurus, Inc. since April 2024. In addition, Behshad Sheldon holds a position as a Member of the Board of Directors at MAXONA Pharmaceuticals and serves as Chair of the Board of Directors for FORCE. Previous roles include EVP & Managing Director at Biotech Value Advisors, Chief Commercial Officer & Head of Development at R-Pharm US, and President & CEO of Braeburn Pharmaceuticals. Education was completed at the University of Rochester with a Bachelor of Science in Neuroscience.